• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625358019
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/10/2022
Event Type  malfunction  
Event Description
We received an allegation of questionable inr results for 1 patient tested with coaguchek xs meter serial number (b)(4) compared to an unknown laboratory method.On (b)(6) 2022 the patient had a meter result of 2.3 inr while the lab result was 1.8 inr.The patient's coumadin dose taken was 7.5 mg based on the lab result.On (b)(6) 2022 the patient had an initial meter result of 2.9 inr while the lab result was 2.2 inr.The time difference between the tests was one hour.The patient's coumadin dose taken was 7.5 mg based on the lab result.The patient's therapeutic range was 2.35-2.75 inr.
 
Manufacturer Narrative
Initial reporter occupation is patient/consumer.The strips were requested for investigation.The product has not been received at this time.If the product is returned in the future, a follow up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.The patient was informed about the possible effect of antibiotics on the measurement result from the coaguchek device.Per product labeling: coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS PT TEST
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16071010
MDR Text Key308290787
Report Number1823260-2022-04235
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 12/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date10/31/2023
Device Catalogue Number04625358019
Device Lot Number60941617
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/12/2022
Initial Date FDA Received12/29/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALDACTON; CORDORAN; COROLAN; COUMADIN; DILATREND; ECO PRIN; FORSIKA; LASIX; MONODUR; PANTOPRAZOLE; SÜTRIL NEO; TAVANIC
Patient Age64 YR
Patient SexMale
Patient Weight63 KG
-
-